CGH Launches Survey to Better Understand Cancer Therapeutic Clinical Trials in Low- and Middle-Income Countries
Have your voice be heard! The National Cancer Institute (NCI) Center for Global Health (CGH) is dedicated to improving cancer control worldwide and developing research programs that are driven by the needs of low- and middle-income countries (LMICs). CGH has launched a survey to better understand the landscape of cancer therapeutic clinical trials in low- and middle-Income countries (LMICs).
We are seeking clinicians who have experience participating as a member of a research team in at least one cancer therapeutic clinical trial who have had or currently have a recruitment site or facility in a LMIC, as defined by the World Bank.
This online survey will take about 15-minutes and is available in English, Spanish, Portuguese, French and Arabic. Responses will help inform a strategic priority for CGH. The survey is anonymous and voluntary. If published, the results will be presented in an aggregated, de-identified format.
Share this announcement with your colleagues and networks and encourage them to take the survey!
If you have any questions, please email us.